Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID04889924

Axillary Lymph Node Dissection Versus Axillary Radiotherapy in Breast Cancer Patients With Positive Sentinel Node After Neoadjuvant Therapy: A Multicenter Randomized Study

Led by Hospital Universitari de Bellvitge · Updated on 2026-05-19

820

Participants Needed

60

Research Sites

130 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying breast cancer patients who have positive sentinel lymph nodes after receiving neoadjuvant systemic treatment. The trial aims to compare two approaches: axillary radiotherapy (ART) without lymph node removal and axillary lymph node dissection (ALND) with radiotherapy. This study evaluates whether ART can reduce the risk of lymphedema without worsening cancer outcomes, including recurrences and overall survival, while also assessing quality of life. Participants will be randomly assigned to one of two groups: one receiving axillary radiotherapy targeting levels I and II and additional areas without lymphadenectomy, and the other undergoing axillary lymph node dissection combined with radiotherapy to other lymph node regions. The study plans to enroll 820 patients over five years, including those treated with chemotherapy or hormone therapy as neoadjuvant treatments. An initial pilot phase involved 200 patients, and an interim analysis will be conducted. Throughout the study, participants will be monitored for disease-free survival up to five years, noting the time until cancer recurrence or death. Researchers will also track overall survival over five years and the incidence of lymphedema for up to three years post-surgery. Quality of life and treatment side effects will be evaluated. Patients will undergo imaging with ultrasound or MRI to assess axillary response, and their treatment completion will be recorded. This comprehensive follow-up ensures careful evaluation of safety and efficacy over time.

CONDITIONS

Brief Title

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with breast cancer stages T1-T4 N0 or T0-T4 N1 and eligible for neoadjuvant treatment
  • Sentinel lymph node with 2 or fewer macrometastases, micrometastases, or isolated tumor cells after neoadjuvant chemotherapy
  • Axillary response confirmed by ultrasound or MRI after neoadjuvant chemotherapy
  • Completed at least 70% of neoadjuvant chemotherapy and 6 months of endocrine treatment
Not Eligible

You will not qualify if you...

  • Clinical nodal stage cN2
  • No evidence of cancer in lymph nodes after treatment (ypN0)
  • History of breast surgery for cancer on the same side within the last 10 years
  • History of other cancers in the last 5 years, except for squamous carcinoma of the skin

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Duration consistent with completion of neoadjuvant therapy and subsequent treatment phases

Participants receive either axillary radiotherapy without lymphadenectomy or axillary lymph node dissection followed by radiotherapy to specific lymph node areas.

1 treatment period with multiple visits as per treatment schedule

Follow-up

Duration - Up to 5 years

Participants are monitored for disease-free survival, overall survival, and lymphedema incidence after completion of treatment.

Regular follow-up visits for up to 5 years

Trial Site Locations

Total: 60 locations

1

GenesisCare Mater

Sydney, New South Wales, Australia, 2060

Actively Recruiting

2

GenesisCare North Shore

Sydney, New South Wales, Australia, 2065

Actively Recruiting

3

GenesisCare Frenchs Forest

Sydney, New South Wales, Australia, 2086

Actively Recruiting

4

GenesisCare Norwest

Sydney, New South Wales, Australia, 2153

Actively Recruiting

5

GenesisCare Hurstville

Sydney, New South Wales, Australia, 2220

Actively Recruiting

6

GenesisCare Campbelltown

Sydney, New South Wales, Australia, 2560

Actively Recruiting

7

Hospital Universitari Germans Trias i Pujol

Badalona, Barcelona, Spain, 08916

Actively Recruiting

8

Instituto Catalán de Oncología de Badalona

Badalona, Barcelona, Spain, 08916

Actively Recruiting

9

Hospital Comarcal Sant Jaume de Calella

Calella, Barcelona, Spain, 08370

Actively Recruiting

10

Hospital General de Granollers

Granollers, Barcelona, Spain, 08402

Not Yet Recruiting

11

Consorci Sanitari Integral

L'Hospitalet de Llobregat, Barcelona, Spain, 08906

Actively Recruiting

12

Hospital Universitario de Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain, 08907

Actively Recruiting

13

Instituto Catalán de Oncología- Hospital Duran i Reynals

L'Hospitalet de Llobregat, Barcelona, Spain, 08908

Actively Recruiting

14

Fundación Althaia Manresa

Manresa, Barcelona, Spain, 08243

Actively Recruiting

15

Hospital de Mataró

Mataró, Barcelona, Spain, 08304

Actively Recruiting

16

Hospital Universitario General de Cataluña

Sant Cugat del Vallès, Barcelona, Spain, 08195

Not Yet Recruiting

17

Hospital Universitario Mútua Terrassa

Terrassa, Barcelona, Spain, 08221

Actively Recruiting

18

Consorci Sanitari de Terrassa

Terrassa, Barcelona, Spain, 08227

Actively Recruiting

19

Hospital de Viladecans

Viladecans, Barcelona, Spain, 08840

Actively Recruiting

20

Hospital Universitario de Cruces

Barakaldo, Bizkaia, Spain, 48903

Actively Recruiting

21

Hospital Universitario Galdakao-Usansolo

Galdakao, Bizkaia, Spain, 48960

Actively Recruiting

22

Hospital Universitario Puerta del Mar

Cadiz, Cádiz, Spain, 11009

Not Yet Recruiting

23

Hospital Universitario de Donostia

Donostia / San Sebastian, Gipuzkoa, Spain, 20014

Actively Recruiting

24

Hospital Universitario Príncipe de Asturias

Alcalá de Henares, Madrid, Spain, 28805

Actively Recruiting

25

Hospital Universitario Severo Ochoa

Leganés, Madrid, Spain, 28914

Actively Recruiting

26

Hospital Universitario Puerta De Hierro

Majadahonda, Madrid, Spain, 28222

Actively Recruiting

27

Hospital Universitario Infanta Cristina

Parla, Madrid, Spain, 28981

Actively Recruiting

28

Hospital Clínico Universitario Virgen de la Arrixaca

El Palmar, Murcia, Spain, 30120

Actively Recruiting

29

Hospital Ribera Povisa

Vigo, Pontevedra, Spain, 36211

Actively Recruiting

30

Hospital Álvaro Cunqueiro

Vigo, Pontevedra, Spain, 36213

Actively Recruiting

31

Hospital Universitario de Canarias

San Cristóbal de La Laguna, Santa Cruz De Tenerife, Spain, 38320

Actively Recruiting

32

Hospital Universitario Sant Joan de Reus

Reus, Tarragona, Spain, 43204

Actively Recruiting

33

Hospital Universitario de A Coruña

A Coruña, Spain, 15006

Actively Recruiting

34

Hospital del Mar

Barcelona, Spain, 08003

Actively Recruiting

35

Hospital de la Santa Cruz y San Pablo

Barcelona, Spain, 08025

Actively Recruiting

36

Hospital Clínico y Provincial de Barcelona

Barcelona, Spain, 08036

Actively Recruiting

37

Hospital Universitario de Burgos

Burgos, Spain, 09006

Actively Recruiting

38

Hospital Universitario de Gerona Doctor Josep Trueta

Girona, Spain, 17007

Actively Recruiting

39

Institut Catalán de Oncología de Girona

Girona, Spain, 17007

Actively Recruiting

40

Hospital Universitario Virgen de las Nieves

Granada, Spain, 18014

Actively Recruiting

41

Hospital Universitario Clínico San Cecilio

Granada, Spain, 18016

Not Yet Recruiting

42

Hospital General Universitario Gregorio Marañón

Madrid, Spain, 28007

Actively Recruiting

43

Hospital Universitario Ramón y Cajal

Madrid, Spain, 28034

Actively Recruiting

44

Hospital Universitario 12 de Octubre

Madrid, Spain, 28041

Actively Recruiting

45

Hospital Universitario La Paz

Madrid, Spain, 28046

Actively Recruiting

46

Hospital Universitario HM Sanchinarro

Madrid, Spain, 28050

Actively Recruiting

47

Hospital Universitario Infanta Sofía- Fundación de Inv. Biomédica H. Infanta Sofía

Madrid, Spain, 28703

Actively Recruiting

48

Hospital Regional Universitario de Málaga

Málaga, Spain, 29010

Actively Recruiting

49

Hospital Universitario Virgen de la Victoria

Málaga, Spain, 29010

Actively Recruiting

50

Hospital Universitario de Navarra

Pamplona, Spain, 31008

Actively Recruiting

51

Hospital Montecelo

Pontevedra, Spain, 36071

Actively Recruiting

52

Hospital Universitario Nuestra Señora de Candelaria

Santa Cruz de Tenerife, Spain, 38010

Actively Recruiting

53

Hospital General de Segovia

Segovia, Spain, 47002

Actively Recruiting

54

Hospital Universitario Virgen Macarena

Seville, Spain, 41009

Actively Recruiting

55

Hospital Universitario de Tarragona Juan XXIII

Tarragona, Spain, 43005

Actively Recruiting

56

Instituto Valenciano de Oncología

Valencia, Spain, 46009

Actively Recruiting

57

Hospital Universitario Doctor Peset

Valencia, Spain, 46017

Actively Recruiting

58

Hospital Clínico Universitario de Valladolid

Valladolid, Spain, 47003

Actively Recruiting

59

Hospital Recoletas Campo Grande de Valladolid

Valladolid, Spain, 47007

Actively Recruiting

60

Hospital Universitario de Álava / Txagorritxu

Vitoria-Gasteiz, Álava, Spain, 01009

Actively Recruiting

Loading map...

Research Team

A

Amparo Garcia-Tejedor, MDPhD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Investigating The Role of Key Non-coding RNA(s) in Breast Ca...

Breast Cancer

Actively Recruiting

1 location

18F-FDG Versus 68Ga-FAPI-46 as PET Tracer in ER-positive Bre...

Breast Cancer

Actively Recruiting

1 location

Evaluation of Diagnostic Value of 18F-T2 PET/ CT Imaging for...

Clear Cell Renal Cell Cancer (ccRCC)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial).

Amparo Garcia-Tejedor, Carlos Ortega-Exposito, Sira Salinas...

https://pubmed.ncbi.nlm.nih.gov/37621686